Pro Share Advisors LLC G1 Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$4.04 - $8.51 $47,869 - $100,834	-11,849 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$7.6 - $11.02 $21,264 - $30,833	-2,798 Reduced 19.1%	11,849 $90,000
Q4 2021 Feb 08, 2022	BUY	$10.16 - $16.17 $5,862 - $9,330	577 Added 4.1%	14,647 $149,000
Q3 2021 Nov 12, 2021	SELL	$13.16 - $22.47 $48,165 - $82,240	-3,660 Reduced 20.64%	14,070 $189,000
Q2 2021 Aug 13, 2021	BUY	$19.57 - $26.32 $55,187 - $74,222	2,820 Added 18.91%	17,730 $389,000
Q1 2021 May 14, 2021	BUY	$17.58 - $32.59 $26,106 - $48,396	1,485 Added 11.06%	14,910 $359,000
Q4 2020 Feb 09, 2021	BUY	$10.99 - $20.4 $34,244 - $63,566	3,116 Added 30.23%	13,425 $242,000
Q3 2020 Nov 13, 2020	SELL	$11.55 - $23.75 $4,146 - $8,526	-359 Reduced 3.37%	10,309 $119,000
Q2 2020 Aug 03, 2020	BUY	$9.57 - $24.37 $102,092 - $259,979	10,668 New	10,668 $259,000
Q1 2020 May 15, 2020	SELL	$9.07 - $26.32 $115,315 - $334,632	-12,714 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$20.54 - $31.0 $26,640 - $40,207	-1,297 Reduced 9.26%	12,714 $336,000
Q3 2019 Nov 12, 2019	BUY	$22.78 - $40.58 $14,123 - $25,159	620 Added 4.63%	14,011 $319,000
Q2 2019 Aug 13, 2019	SELL	$16.03 - $31.1 $29,495 - $57,224	-1,840 Reduced 12.08%	13,391 $411,000
Q1 2019 May 15, 2019	BUY	$14.4 - $21.45 $3,283 - $4,890	228 Added 1.52%	15,231 $253,000
Q4 2018 Feb 14, 2019	SELL	$16.51 - $51.33 $19,283 - $59,953	-1,168 Reduced 7.22%	15,003 $287,000
Q3 2018 Nov 14, 2018	SELL	$43.15 - $67.97 $11,219 - $17,672	-260 Reduced 1.58%	16,171 $846,000
Q2 2018 Aug 13, 2018	BUY	$35.06 - $51.17 $54,483 - $79,518	1,554 Added 10.45%	16,431 $714,000
Q1 2018 May 14, 2018	SELL	$19.05 - $41.76 $29,737 - $65,187	-1,561 Reduced 9.5%	14,877 $551,000
Q4 2017 Feb 14, 2018	BUY	$19.01 - $26.2 $312,486 - $430,675	16,438	16,438 $326,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account